Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

BMS-207147

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2002
2002
Ravuconazole (BMS-207147, ER-30346), an oral triazole, was evaluated in an immunosuppressed temporarily neutropenic guinea pig… Expand
Highly Cited
2001
Highly Cited
2001
ABSTRACT The most important role of susceptibility testing is to identify potentially resistant isolates for the agent being… Expand
  • table 1
  • table 2
  • table 3
  • table 4
  • table 5
2001
2001
ABSTRACT The effect of germinated and nongerminated conidia ofAspergillus spp. on the fungistatic (National Committee for… Expand
  • table 1
  • table 2
Highly Cited
2000
Highly Cited
2000
ABSTRACT The in vitro activities of the new triazole, ravuconazole (BMS-207147), were compared to those of fluconazole and… Expand
  • table 1
  • figure 1
  • figure 2
Highly Cited
2000
Highly Cited
2000
ABSTRACT The in vitro activity of BMS-207147 against 80 clinical isolates ofAspergillus was compared with that of itraconazole… Expand
  • table 1
  • figure 1
Highly Cited
1999
Highly Cited
1999
The SENTRY Antimicrobial Surveillance Program, an international study of blood stream infections (BSIs), detected 170 episodes of… Expand
1999
1999
The activities of itraconazole and the new triazole BMS-207147 were determined against Candida strains that were susceptible-dose… Expand
1999
1999
ABSTRACT We compared the in vitro activity of BMS-207147, an investigational triazole, with those of itraconazole and fluconazole… Expand
Highly Cited
1998
Highly Cited
1998
ABSTRACT The antifungal activity of BMS-207147 (also known as ER-30346) was compared to those of itraconazole and fluconazole… Expand
  • table 1
  • table 2
  • table 3
  • table 5
  • table 6
Highly Cited
1998
Highly Cited
1998
ABSTRACT BMS-207147, Sch 56592, and voriconazole are three new investigational triazoles with broad-spectrum antifungal activity… Expand
  • table 1
  • table 2